Abstract
Embryo implantation requires a receptive endometrium under the influence of tightly regulated endocrine signaling from both the embryo and the corpus luteum. Research has found that after IVF, additional support for the endometrium with exogenous progesterone improves implantation and subsequent live birth rates. The purpose of this study is to investigate the potential benefit of a short acting GnRH agonist (GnRHa), leuprolide acetate, for support of the luteal phase endometrium prior to embryo implantation in IVF.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
